Andrea L. Frohning
CIK 1591945 · View on SEC EDGAR ↗
First SEC filing: March 6, 2026 · Latest: March 6, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 7, 2026 | XRAY | F | 802 | $12.12 | $9,720 | 63,191 Direct | -1.25% | Disposed | -10.5% (price as of 2026-08-21) |
| March 4, 2026 | XRAY | A | 121,600 | — | — | 121,600 Direct | — | Acquired | (price as of 2026-08-21) |
| March 4, 2026 | XRAY | A | 26,786 | — | — | 63,992 Direct | +71.99% | Acquired | (price as of 2026-08-21) |
| March 4, 2026 | XRAY | F | 690 | $13.44 | $9,274 | 37,206 Direct | -1.82% | Disposed | -19.3% (price as of 2026-08-21) |
| March 3, 2026 | XRAY | F | 1,977 | $13.30 | $26,294 | 37,896 Direct | -4.96% | Disposed | -18.4% (price as of 2026-08-21) |
| March 3, 2026 | XRAY | F | 2,990 | $13.30 | $39,767 | 39,873 Direct | -6.98% | Disposed | -18.4% (price as of 2026-08-21) |
| March 2, 2026 | XRAY | A | 8,861 | — | — | 42,863 Direct | +26.06% | Acquired | (price as of 2026-08-21) |
| Jan. 9, 2026 | XRAY | A | 23 | $12.22 | $281 | 1,759 Direct | +1.32% | Acquired | -11.2% (price as of 2026-08-21) |
| Jan. 9, 2026 | XRAY | A | 392 | — | — | 34,002 Direct | +1.17% | Acquired | (price as of 2026-08-21) |
| Oct. 10, 2025 | XRAY | A | 23 | $11.98 | $276 | 1,737 Direct | +1.34% | Acquired | -9.4% (price as of 2026-08-21) |
| Oct. 10, 2025 | XRAY | A | 357 | — | — | 33,610 Direct | +1.07% | Acquired | (price as of 2026-08-21) |
| Aug. 8, 2025 | XRAY | F | 788 | $12.96 | $10,212 | 33,253 Direct | -2.31% | Disposed | -16.3% (price as of 2026-08-21) |
| July 11, 2025 | XRAY | A | 17 | $16.20 | $275 | 1,714 Direct | +1.00% | Acquired | -33.0% (price as of 2026-08-21) |
| July 11, 2025 | XRAY | A | 305 | — | — | 34,041 Direct | +0.90% | Acquired | (price as of 2026-08-21) |
| April 11, 2025 | XRAY | A | 21 | $12.47 | $262 | 1,697 Direct | +1.25% | Acquired | -13.0% (price as of 2026-08-21) |
| April 11, 2025 | XRAY | A | 322 | $1.00 | $322 | 33,736 Direct | +0.96% | Acquired | 985.0% (price as of 2026-08-21) |
| March 4, 2025 | XRAY | F | 792 | $15.59 | $12,347 | 33,415 Direct | -2.32% | Disposed | -30.4% (price as of 2026-08-21) |
| March 3, 2025 | XRAY | A | 207,500 | — | — | 207,500 Direct | — | Acquired | (price as of 2026-08-21) |
| March 3, 2025 | XRAY | A | 20,013 | — | — | 34,207 Direct | +141.00% | Acquired | (price as of 2026-08-21) |
| Jan. 10, 2025 | XRAY | A | 14 | $18.51 | $259 | 1,675 Direct | +0.84% | Acquired | -41.4% (price as of 2026-08-21) |
| Jan. 10, 2025 | XRAY | A | 103 | — | — | 14,194 Direct | +0.73% | Acquired | (price as of 2026-08-21) |
| Oct. 11, 2024 | XRAY | A | 11 | $24.50 | $270 | 1,661 Direct | +0.67% | Acquired | -55.7% (price as of 2026-08-21) |
| Oct. 11, 2024 | XRAY | A | 72 | — | — | 14,090 Direct | +0.51% | Acquired | (price as of 2026-08-21) |
| Aug. 9, 2024 | XRAY | F | 768 | $24.13 | $18,532 | 14,019 Direct | -5.19% | Disposed | -55.0% (price as of 2026-08-21) |
| July 12, 2024 | XRAY | A | 10 | $25.80 | $258 | 1,650 Direct | +0.61% | Acquired | -57.9% (price as of 2026-08-21) |
| July 12, 2024 | XRAY | A | 94 | — | — | 14,787 Direct | +0.64% | Acquired | (price as of 2026-08-21) |
| April 12, 2024 | XRAY | A | 8 | $31.45 | $252 | 1,640 Direct | +0.49% | Acquired | -65.5% (price as of 2026-08-21) |
| April 12, 2024 | XRAY | A | 70 | — | — | 14,692 Direct | +0.48% | Acquired | (price as of 2026-08-21) |
| March 18, 2024 | XRAY | A | 1,632 | $35.59 | $58,083 | 1,632 Direct | — | Acquired | -69.5% (price as of 2026-08-21) |
| March 4, 2024 | XRAY | A | 22,600 | — | — | 22,600 Direct | — | Acquired | (price as of 2026-08-21) |
| March 4, 2024 | XRAY | A | 6,761 | — | — | 14,622 Direct | +86.01% | Acquired | (price as of 2026-08-21) |
| Jan. 12, 2024 | XRAY | A | 31 | — | — | 7,861 Direct | +0.40% | Acquired | (price as of 2026-08-21) |
| Oct. 13, 2023 | XRAY | A | 32 | — | — | 7,830 Direct | +0.41% | Acquired | (price as of 2026-08-21) |
| Aug. 9, 2023 | XRAY | A | 24,500 | — | — | 24,500 Direct | — | Acquired | (price as of 2026-08-21) |
| Aug. 9, 2023 | XRAY | A | 7,798 | — | — | 7,798 Direct | — | Acquired | (price as of 2026-08-21) |
| Jan. 26, 2016 | CXT | M | 288 | — | — | 2,424 Direct | -10.62% | Disposed | (price as of 2026-08-21) |
| Jan. 26, 2016 | CXT | F | 113 | $46.52 | $5,257 | 805 Direct | -12.31% | Disposed | 211.1% (price as of 2026-08-21) |
| Jan. 26, 2016 | CXT | M | 288 | — | — | 918 Direct | +45.71% | Acquired | (price as of 2026-08-21) |
| Dec. 9, 2015 | CXT | M | 345 | — | — | 2,712 Direct | -11.29% | Disposed | (price as of 2026-08-21) |
| Dec. 9, 2015 | CXT | F | 117 | $48.63 | $5,690 | 630 Direct | -15.66% | Disposed | 197.6% (price as of 2026-08-21) |
| Dec. 9, 2015 | CXT | M | 345 | — | — | 747 Direct | +85.82% | Acquired | (price as of 2026-08-21) |
| Jan. 27, 2015 | CXT | M | 289 | — | — | 3,057 Direct | -8.64% | Disposed | (price as of 2026-08-21) |
| Jan. 27, 2015 | CXT | F | 114 | $58.82 | $6,705 | 402 Direct | -22.09% | Disposed | 146.1% (price as of 2026-08-21) |
| Jan. 27, 2015 | CXT | M | 289 | — | — | 516 Direct | +127.31% | Acquired | (price as of 2026-08-21) |
| Jan. 26, 2015 | CXT | A | 1,154 | — | — | 3,346 Direct | +52.65% | Acquired | (price as of 2026-08-21) |
| Jan. 26, 2015 | CXT | A | 15,974 | — | — | 15,974 Direct | — | Acquired | (price as of 2026-08-21) |
| Jan. 26, 2015 | CXT | A | 3,682 | — | — | 3,682 Direct | — | Acquired | (price as of 2026-08-21) |
| Dec. 9, 2014 | CXT | M | 344 | — | — | 2,192 Direct | -13.56% | Disposed | (price as of 2026-08-21) |
| Dec. 9, 2014 | CXT | J | 48 | — | — | 48 Indirect | — | Acquired | (price as of 2026-08-21) |
| Dec. 9, 2014 | CXT | F | 117 | $57.72 | $6,753 | 227 Direct | -34.01% | Disposed | 150.7% (price as of 2026-08-21) |
| Dec. 9, 2014 | CXT | M | 344 | — | — | 344 Direct | — | Acquired | (price as of 2026-08-21) |
| Jan. 27, 2014 | CXT | A | 1,158 | — | — | 2,536 Direct | +84.03% | Acquired | (price as of 2026-08-21) |
| Jan. 27, 2014 | CXT | A | 13,922 | — | — | 13,922 Direct | — | Acquired | (price as of 2026-08-21) |
| Jan. 27, 2014 | CXT | A | 4,088 | — | — | 4,088 Direct | — | Acquired | (price as of 2026-08-21) |
| Dec. 9, 2013 | CXT | A | 1,378 | — | — | 1,378 Direct | — | Acquired | (price as of 2026-08-21) |
| Dec. 9, 2013 | CXT | A | 10,290 | — | — | 10,290 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 4, 2026 | XRAY | Stock Option (Right to Buy) | Common Stock (121,600) | $14.78 | March 4, 2036 | 121,600 | Acquired |
| Jan. 9, 2026 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock (23) | — | — | 23 | Acquired |
| Oct. 10, 2025 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock (23) | — | — | 23 | Acquired |
| July 11, 2025 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock (17) | — | — | 17 | Acquired |
| April 11, 2025 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock (21) | — | — | 21 | Acquired |
| March 3, 2025 | XRAY | Stock Option (Right to Buy) | Common Stock (207,500) | $15.99 | March 3, 2035 | 207,500 | Acquired |
| Jan. 10, 2025 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock (14) | — | — | 14 | Acquired |
| Oct. 11, 2024 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock (11) | — | — | 11 | Acquired |
| July 12, 2024 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock (10) | — | — | 10 | Acquired |
| April 12, 2024 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock (8) | — | — | 8 | Acquired |
| March 18, 2024 | XRAY | Phantom Stock (Supplemental Executive Retirement Plan) SERP | Common Stock (1,632) | — | — | 1,632 | Acquired |
| March 4, 2024 | XRAY | Stock Option (Right to Buy) | Common Stock (22,600) | $33.28 | March 4, 2034 | 22,600 | Acquired |
| Aug. 9, 2023 | XRAY | Stock Option (Right to Buy) | Common Stock (24,500) | $38.47 | Aug. 9, 2033 | 24,500 | Acquired |
| Jan. 26, 2016 | CXT | Restricted Share Unit | CRANE CO. COMMON, PAR VALUE $1.00 (288) | — | — | 288 | Disposed |
| Dec. 9, 2015 | CXT | Restricted Share Unit | CRANE CO. COMMON, PAR VALUE $1.00 (345) | — | — | 345 | Disposed |
| Jan. 27, 2015 | CXT | Restricted Share Unit | CRANE CO. COMMON, PAR VALUE $1.00 (289) | — | — | 289 | Disposed |
| Jan. 26, 2015 | CXT | Restricted Share Unit | CRANE CO. COMMON, PAR VALUE $1.00 (1,154) | — | — | 1,154 | Acquired |
| Jan. 26, 2015 | CXT | Employee Stock Option (Right to Buy) | CRANE CO. COMMON, PAR VALUE $1.00 (15,974) | $58.47 | Jan. 26, 2025 | 15,974 | Acquired |
| Jan. 26, 2015 | CXT | 2015 Performance-Based Restricted Share Unit | CRANE CO. COMMON, PAR VALUE $1.00 (3,682) | — | — | 3,682 | Acquired |
| Dec. 9, 2014 | CXT | Restricted Share Unit | CRANE CO. COMMON, PAR VALUE $1.00 (344) | — | — | 344 | Disposed |
| Jan. 27, 2014 | CXT | Restricted Share Unit | CRANE CO. COMMON, PAR VALUE $1.00 (1,158) | — | — | 1,158 | Acquired |
| Jan. 27, 2014 | CXT | Employee Stock Option (Right to Buy) | CRANE CO. COMMON, PAR VALUE $1.00 (13,922) | $64.78 | Jan. 27, 2024 | 13,922 | Acquired |
| Jan. 27, 2014 | CXT | 2014 Performance-Based Restricted Share Unit | CRANE CO. COMMON, PAR VALUE $1.00 (4,088) | — | — | 4,088 | Acquired |
| Dec. 9, 2013 | CXT | Restricted Share Unit | CRANE CO. COMMON, PAR VALUE $1.00 (1,378) | — | — | 1,378 | Acquired |
| Dec. 9, 2013 | CXT | Employee Stock Option (Right to Buy) | CRANE CO. COMMON, PAR VALUE $1.00 (10,290) | $65.30 | Dec. 9, 2019 | 10,290 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).